Clinical Trial Update: Flutiform® Compared With Seretide® in the Treatment of COPD [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial compared Flutiform with Seretide for treating chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)
• Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2, Phase 3 | Status: COMPLETED